Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

26.30 -0.03 (-0.11%)

Official Closing Price Updated: 7:00 PM EDT, May 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

99 100 Next >

Market Resilience Tested: How Investors Can Navigate U.S. Government Shutdowns

November 10, 2025

As the U.S. political landscape continues to present its unique set of challenges, the specter of a government shutdown remains a perennial concern for investors. These periods, marked by a cessation...

Via MarketMinute

Wall Street Cheers as Senate Vote Signals End to Record-Breaking US Government Impasse

November 10, 2025

Global equity markets have surged in early November 2025, fueled by renewed optimism that the United States government's historic shutdown, which commenced on October 1, 2025, may finally be nearing...

Via MarketMinute

Topics Economy Workforce

Pfizer CEO Reportedly Drops F-Bomb On Live TV Discussing Seagen, Metsera Deals ↗

November 10, 2025

Via Stocktwits

Cogent Biosciences' Lead Cancer Drug Cuts Disease Progression Or Death Risk By 50% In Stomach Cancer Trial ↗

November 10, 2025

Cogent Biosciences stock rises as bezuclastinib plus Sutent shows 50% lower progression risk and strong efficacy in Phase 3 GIST trial.

Via Benzinga

Metsera Tumbles After The Pfizer-Novo Buyout Battle Ends At $10 Billion ↗

November 10, 2025

The final bid, at $10 billion, is expected to wrap up after Nov. 13 with the next shareholders' vote.

Via Investor's Business Daily

Topics Initial Public Offering

Markets Breathe Sigh of Relief as Historic Government Shutdown Nears Resolution

November 10, 2025

Washington D.C. – November 10, 2025 – The United States stock market is experiencing a significant uplift today, as news of an impending resolution to the nation's longest-ever government shutdown...

Via MarketMinute

Topics Economy Government

Monday.Com, Metsera, Profrac Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

November 10, 2025

Via Benzinga

Why Viasat Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

November 10, 2025

Via Benzinga

3 Cash-Producing Stocks We Think Twice About

November 10, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

Novo Nordisk Loses Metsera Bidding War To Pfizer — But Retail Traders Aren’t Losing Faith ↗

November 09, 2025

Novo investors on Stocktwits praised new CEO Mike Doustdar as “dynamic,” saying they remain confident in Novo’s long-term obesity and diabetes pipeline despite short-term setbacks.

Via Stocktwits

Market Reels from Volatility and Mixed Signals: A Deep Dive into Investor Unease

November 08, 2025

The past week, from November 1st to November 8th, 2025, has witnessed a significant shift in global market sentiment, moving decisively towards a "risk-off" stance. Investors are grappling with...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

2 No-Brainer Dividend Stocks to Buy With $100 in November ↗

November 08, 2025

There's no need to break the bank to get your hands on excellent dividend payers.

Via The Motley Fool

Topics Economy World Trade

Eli Lilly Strikes a Landmark Pricing Deal With the U.S. for Its Billion-Dollar Weight Loss Drugs. Here's What This Means for Investors. ↗

November 08, 2025

Weight loss drugs generated about $10 billion for Lilly in the most recent quarter.

Via The Motley Fool

Topics Government

Global Virtual Summit Puts the Spotlight on Sickle Cell Caregivers

November 08, 2025

November 8, 2025 -- Four-Day Event Unites Families, Advocates, and Medical Experts to Prioritize Mental Wellness, Advocacy, and Legacy

Via 24-7 Press Release

Pfizer Clinches $10 Billion Deal To Buy Obesity Drug Maker Metsera, Outbidding Novo Nordisk In Fierce Battle For Weight-Loss Market Dominance ↗

November 08, 2025

Nvidia CEO Jensen Huang cautioned Elon Musk against underestimating the challenges of semiconductor manufacturing, saying building a chip fab like TSMC's is "extremely hard."

Via Benzinga

Deal Dispatch: From A Founder Comeback To Billion-Dollar Bids, This Week In M&A And Bankruptcy ↗

November 07, 2025

Via Benzinga

Why Novo Nordisk Stock Is Sinking This Week ↗

November 07, 2025

The global drugmaker is facing some headwinds related to tough competition.

Via The Motley Fool

Topics Government World Trade

The Stock Market Is Signaling a Recession. Here's How to Prepare Your Portfolio.

November 07, 2025

The financial markets are increasingly flashing warning signs that an economic recession may be on the horizon, prompting investors to re-evaluate their strategies. A confluence of indicators, from...

Via MarketMinute

Topics Bonds Economy Stocks

Friday's session: most active stock in the S&P500 index ↗

November 07, 2025

Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest and driving market movements.

Via Chartmill

Tech Sell-Off Rocks Wall Street: Nasdaq, S&P 500, and Dow Sink Amidst Brutal Week for Stocks

November 07, 2025

New York, NY – November 7, 2025 – The U.S. stock market has been gripped by a significant downturn in early November 2025, culminating in a brutal week that saw the Nasdaq Composite, S&P 500, and Dow...

Via MarketMinute

Topics Artificial Intelligence Economy Retirement

The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things. ↗

November 07, 2025

The feast that saw obesity-tied stocks skyrocket in 2024 is over. Investors' appetite for weight-loss drugs has waned.

Via Investor's Business Daily

Topics Government

Sangamo (SGMO) Q3 2025 Earnings Call Transcript ↗

November 06, 2025

Sangamo (SGMO) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

US Stocks Tumble Amid AI Valuation Fears and Mounting Job Worries

November 06, 2025

The U.S. stock market experienced a notable downturn today, November 6, 2025, as investors grappled with growing apprehension over the lofty valuations of artificial intelligence (AI) stocks and a...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Famed Investor Michael Burry Bets Against Nvidia and Palantir to the Tune of $1.1 billion. Is He Right? ↗

November 06, 2025

Burry is famous for shorting the market during the mortgage crisis. Is he going to win big again?

Via The Motley Fool

Topics Artificial Intelligence

AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures

November 06, 2025

A groundbreaking $2 million grant from the National Institutes of Health (NIH) is set to dramatically accelerate advancements in gene-editing technology, with artificial intelligence (AI) emerging as...

Via TokenRing AI

Topics Artificial Intelligence Climate Change Intellectual Property

Eli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx ↗

November 06, 2025

The Trump administration struck deals with Eli Lilly and Novo Nordisk to lower obesity drug prices and expand Medicare coverage starting in 2026.

Via Benzinga

Topics Government

Stay informed about the most active stocks in the S&P500 index on Thursday's session. ↗

November 06, 2025

Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Thursday. Discover the stocks that are generating the highest...

Via Chartmill

3 Value Stocks That Fall Short

November 06, 2025

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are...

Via StockStory

Pfizer To Raise Metsera Bid After Court Denies Attempt To Block Rival Deal ↗

November 06, 2025

Delaware court denies Pfizer bid to block Metsera's Novo Nordisk deal as FTC flags antitrust risks and Pfizer prepares a higher counteroffer.

Via Benzinga

Novo Nordisk Reportedly Refrains From Backing Down In Metsera Acquisition Battle, Sweetens Bid Further ↗

November 06, 2025

According to an FT report, Pfizer now has two days to match Novo’s new bid or let its agreed-upon deal with Metsera fall through.

Via Stocktwits

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.